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ABSTRACT: 
Due to the increasing incidence of law suits involving malpractice claims in the 
United States, health professionals must be proactive in informing their patients about the 
risks and benefits, and the possible side effects of any procedure. A hand written entry in 
the patient's record or the patient's signature on a consent form should be completed for 
each of the following: pupillary dilation or a cycloplegic examination, the use of contact 
lenses and their care, particularly with extended wear soft contact lenses, and prolonged 
drug therapies as found in the treatment of glaucoma. In addition to discussing the issues 
necessary to understand informed consent, this paper includes forms that may be helpful 
for the practitioner. 
INTRODUCTION 
Informed consent goes beyond the legal aspects of ensuring that the patient is 
informed of the nature, purpose, risks and benefits of an optometric procedure. It builds 
the ethical foundation in which the doctor ensures that the patient's health care needs are 
fully met. 1 Informed consent formalizes both the ethical and legal relationship between 
the patient and the doctor. 
In previous years, patients seldom questioned the treatment options offered by the 
physician. This is still the case in several nations, but medicine in the United States has 
taken a different trend. For the past fifty years, the increasing threat of malpractice 
litigation has resulted in the need for informed consent. 
Informed consent can be defined as a patient's authorization to a doctor to initiate 
a procedure or a treatment plan. This is valid only if the patient is fully informed of the 
nature of the procedure, its risks and benefits, and the alternative options available to the 
patient. 2 Once the patient understands these elements, he/she can choose to undergo or 
forego the procedure or treatment. Regardless of the option that the patient chooses, the 
doctor needs to offer treatment that conforms to a certain standard of care to ensure that 
the patient is protected from harm} If a practitioner fails to adhere to this, he/she may be 
inviting a malpractice lawsuit. 
The first reported case of optometric malpractice in 1939 established that 
optometrists would be held liable if they did not meet an expected standard of care. 4 
John Classe offers us an ideal definition of the standard of care stating that "a doctor is 
expected to exercise reasonable care in the treatment of his patients and to possess a 
standard minimum of special knowledge and ability. "5 In most jurisdictions, the standard 
of care is based upon the patient's ability to understand, and the physician must disclose 
whatever information is pertinent to allow a reasonable patient to make a decision about 
their medical care. 6 
Other than the failure to adhere to a standard of care, there are several other 
sources for litigation. In fact, the most common cause of malpractice suits against 
optometry is misdiagnosis.? This includes the failure to detect a disease or to inaccurately 
diagnose disease in a patient who is healthy. If disease is detected, the optometrist must 
obtain proper referral in a timely manner as the failure to refer and the failure to follow a 
patient are also sources for malpractice suits.4 In 1980, the National Association of 
Insurance Commissioners (NAIC) performed a study which compared malpractice claims 
by profession between 1975 and 1978.7 Of five professions compared by Classe, 
optometry had only 40 malpractice claims filed during this three year period. This is the 
lowest number of any of the professions studied. Ophthalmology had the highest number 
of claims with 354 claims filed during this period. In addition ophthalmology paid twice 
the amount as optometry did per claim. Regardless of the number of claims or the 
expenses involved, the most common error for optometrists was misdiagnosis. 
Even though there are several avenues leading to malpractice, John Classe offers 
fifteen pointers in his "Legal Aspects of Optometry" to help optometrists avoid 
malpractice but warns us that "no one is immune from suit. "7 To further minimize 
malpractice lawsuits, informed consent forms should be completed for such things as 
pupillary dilation, the use of contact lenses, and prolonged drug therapies. 
INFORMED CONSENT: 
The decision made by the patient to either accept or reject the procedure to be 
performed or the treatment offered needs to be documented as informed consent. This 
can be done by making a handwritten entry in the patient's record or by using a 
standardized consent form. If a standardized consent form is used, double ply NCR paper 
is highly recommended because it allows the original form to be kept in the patient's file 
and a copy to be given to the patient for his or her personal records. 
Any standardized informed consent must address the nature of the procedure or 
treatment, its risks and benefits, and any possible side effects.6 These items are known as 
the elements of disclosure. The nature of a procedure must be described to the patient 
clearly and in understanding terms. It may include the part of the body that is involved 
and whether the procedure is invasive or not. It must also indicate if a procedure is 
diagnostic or therapeutic. If the procedure is therapeutic, the informed consent must 
include the expected duration of treatment and indicate the need for local or general 
anesthetic. If a procedure is experimental or a part of research project, this must also be 
clear to the patient. 
The most important element to be included in the informed consent is the risk 
associated with or secondary to the procedure or therapy. The nature, magnitude and the 
probability of the risk developing must be explained. For example, for pupillary dilation 
the nature of the risk includes angle closure which may result in loss of vision. The 
probability of the risk materializing in a Von Herrick grade 4+ angle is minimal but quite 
substantial for a 1 or 2+ angle. In some states, the remote or minor risks where the 
patient will not suffer substantial harm or discomfort, need not be disclosed to the 
-reasonable patient. These are referred to as the negative elements of disclosure as they 
would not alter the decision made by a reasonable patient. 6 
The inclusion of the benefits of a procedure or treatment plan is not crucial. 
However they do need to be mentioned if a procedure is diagnostic. For example, 
pupillary dilation is beneficial to the patient because it allows the doctor to view the 
interior of the eye and better detect any disease which may be present. Even though the 
benefits of a procedure are not essential, the failure to disclose them may cause a patient 
to question the need for the procedure to be performed. 
Once the elements of disclosure have been explained to the patient, he/she is 
responsible for making a decision to undergo or refuse the procedure or treatment. 
Essentially the definition of informed consent is that the patient fully understands the 
procedure or treatment and based on that understanding he/she chooses to undergo or 
forego the procedure. If a patient refuses treatment, alternatives or options to the 
recommended therapy must be offered. Again, the nature, risks and benefits of the 
alternative therapy should be disclosed. In most cases the alternative is less preferable to 
the initial therapy plan usually due to decreased effectivity or increased side effects.6 The 
patient must understand this difference. 
Regardless of the method informed consent is obtained, three signatures are 
essential for a consent form. These include the signature of the patient (or a 
parent/guardian if the patient is a minor), the signature of the doctor performing the 
procedure or administering the treatment, and the signature of a witness. Another 
important element in standardized consent forms is that the procedure or treatment must 
be explained in non technical terms which allows the patient to understand the content of 
the fonn. 8 
Pupillary Dilation 
Now that each state allows the use of diagnostic pham1aceutical agents, pupillary 
dilation is considered the standard of care.9 Failure to routinely dilate all first time 
patients, patients that are at an increased risk for ocular diseases such as high myopes, 
diabetics and patients with a high risk of glaucoma, or patients that present with 
symptoms that indicate the need for pupillary dilation may result in a malpractice lawsuit. 
However, merely dilating these patients without educating them about the nature, risks 
and benefits of pupillary dilation may also lead to litigation. The patient must be 
educated about the increased ability to detect disease through pupillary dilation which 
allows prompt treatment when necessary. In addition, they must be warned that their 
ability to drive or work may be impaired secondary to the blurred vision which they may 
experience. With all this information at hand, if a patient still refuses to undergo 
pupillary dilation , an informed consent fonn must be signed indicating refusal.lO 
It is important to take a thorough case history to ensure that a patient has not had 
an adverse reaction to pupillary dilation in the past. Even though the probability of an 
angle narrow enough to result in angle closure is only 0.4-1.64% 11 , anterior chamber 
angles must be checked with either the Von Herrick technique or gonioscopy. Regardless 
of whether the patient has narrow angles and is at risk for angle closure, all patients 
should sign an informed consent form prior to undergoing pupillary dilation. This greatly 
reduces the chance of litigation and educates the patient on the procedure, risks, benefits 
and side effects. If such a detailed consent form is not available, a note in the patient's 
file must indicate that you have warned the patient of the risks, benefits and side effects 
of the procedure. In the case where the procedure is refused, a succinct chart note should 
be made indicating the patient's decision. 
INFORMED CONSENT FOR ROUTINE PUPILLARY DILATION 
Pupillary dilation is a common procedure used by eye care practitioners which allows the examiner to 
view the structures inside the eye. This provides a more thorough examination and aids the doctor in 
detecting disease or ensuring that your eyes are healthy. 
In order to dilate your pupils, the following drops must be administered: 
Time: __________ _ 
It may take upto half an hour before your pupils are as large as they can be. Once this happens, most 
people will be more sensitive to light. Sunglasses will reduce this sensitivity. If you do not have a pair of 
sunglasses with you today, the office will provide you with a pair of disposable ones. Your ability to see 
clearly, particularly up close, will be temporarily impaired and you may also have blurry vision in the 
distance. If you experience this blur it will take four to six hours before you are able to see clearly again. 
Please use extreme caution when walking, climbing up or down stairs and driving during this time. If 
you have any special transportation needs please let one of our staff members know and we will be happy 
to arrange it for you prior to this procedure. 
In approximately 0.4-1.64% of the population, there is risk of developing increased pressure inside your 
eyes with pupillary dilation. If you are at risk the doctor will discuss it with you because it is important 
that you understand this complication before consenting to and undergoing this procedure. If the pressure 
in your eyes is elevated after pupillary dilation, it may be necessary to administer a second set of 
eyedrops or use oral medications to decrease the pressure. In addition, you may need to undergo surgical 
treatment to prevent this from occurring again. 
We highly recommend that you have your pupils dilated because it allows the doctor to look for the 
presence of eye diseases. Some diseases such as glaucoma typically have no symptoms and you may not 
be aware of them until you have lost vision permanently. The earlier a disease is found the more likely it 
is to be treated successfully. 
You have the right to refuse this procedure. If you have questions about any of the information that has 
been provided to you, please ask us so that we are able to address your concerns. 
Please check the appropriate box and then sign the fonn in the presence of the doctor or one of our office 
staff. 
] I understand the risks, benefits and side effects of pupillary dilation and chose to undergo the 
procedure. 
[ ] The risks, benefits and side effects of pupillary dilation have been explained to me, nevertheless, I 
refuse to undergo the procedure. 
Signature of the Patient/Parent/Guardian Date 
Signature of the Doctor Date 
Signature of a Witness Date 
Extended Wear Contact Lenses 
During the 1960's claims against optometrists increased by one third. One of the 
two reasons for this increase was contact lenses. 47% of the contact lens claims filed 
were due to injuries that the patients had incurred from wearing the lenses. 7 Therefore 
contact lens patients need to be informed of the risks and benefits associated with contact 
lens wear. Since compliance is important for healthy and successful contact lens wear, a 
fitting, service and compliance agreement is useful to protect oneself against liability and 
to educate the patient on its critical importance. Even though some patients will present 
to your office for contact lenses only, a complete eye health evaluation including 
pupillary dilation must be performed prior to fitting the patient. 
Extended wear contact lenses impose a greater responsibility on the eye care 
practitioner. Since many patients have poor compliancei2 and because extended wear 
lenses are associated with an increased risk of infection, 13 special attention in the 
selection of the contact lens material, the care regimen and timely follow up care on the 
part of the doctor is essential. Informed consent helps protect the doctor against a lawsuit 
by helping the patient understand the risks of extended wear contact lenses, the 
importance of periodic checks and the possibility that the extended wear schedule may 
need to be discontinued. These patients must also be educated on the signs and 
symptoms of corneal ulcers and advised that if they experience persistent redness or pain, 
cloudy or foggy vision or unusual symptoms at any time, an immediate office visit should 
be made. 
The following consent form also includes that patient failure to adhere to the care 
regimen which has been selected by both the doctor and the patient, or to attend follow up 
appointments make the patient solely responsible for the health of his/her eyes. The type 
of lens and care regimen selected should be the outcome of a discussion between the 
patient and the doctor. This allows the doctor to fit the optimal lens and place the patient 
on a care regimen that fits comfortably into the patient's schedule to improve both patient 
compliance and satisfaction. 
INFORMED CONSENT AND CONTACT LENS COMPLIANCE 
Contact lenses are medical devices that are used for the correction of nearsightedness, farsightedness, 
presbyopia, keratoconus and other anomalies. Even though contact lenses are manufactured specifically 
for the human eye, they can cause severe complications when the correct care regimen is not followed. It 
is important for you to understand this before you start wearing contact lenses. 
You have the following type of contact lens: 
[ ] Daily wear rigid gas permeable 
These contact lenses are worn on a daily basis ONLY and must be removed from the eye daily, 
cleaned thoroughly and stored in the appropriate solution. They must not be worn overnight These 
lenses need to be replaced at least every 12-18 months. 
[ ] Daily wear soft hydrophilic contact lenses 
These contact lenses are worn on a daily basis ONLY and must be removed from the eye daily, 
cleaned thoroughly, and stored in a disinfecting solution overnight. These contact lenses must be 
replaced at least every 9-12 months. 
[ ] Daily wear soft hydrophilic contact lenses, planned replacement 
These contact lenses are worn on a daily basis ONLY and must be removed from the eye daily 
cleaned thoroughly, and stored in a disinfecting solution overnight. These contact lenses must be 
replaced every _ _ weeks. 
[ ] Extended wear soft hydrophilic contact lenses, disposable 
These contact lenses need to be removed from the eye and thrown away at least every __ days. 
They should be replaced with a new, sterile pair of contact lenses . These contact lenses require 
responsibilities unlike those for soft daily wear lenses. 
Based on the type of contact lenses that you and your doctor have decided is best for your schedule, you 
have been placed on the following care regimen: 
Name of solution Times per week needed 
Name of solution Times per week needed 
Name of enzyme Times per month needed 
Based on the contact lens that has been chosen by you and your doctor a follow up contact lens check is 
required every _, _, and _ months to ensure your eyes stay healthy . 
I fully understand that I must comply with the appropriate care regimen in order to ensure my eyes stay 
healthy. If I chose to adhere to another care regimen that does not follow the parameters of this 
agreement, then I am solely responsible for the health of my eyes. 
In addition I understand the importance of periodic appointments and agree to keep them. 
Signature of the Patient/Parent/Guardian Date 
Signature of the doctor Date 
Therapeutic Treatment 
The passage of therapeutic drug laws has caused a new trend in optometry to 
occur which has also increased the potential source for liability. Most of the malpractice 
cases reported involve prolonged corticosteroid therapy which lead to fungal growth, 
cataract formation and steroid induced glaucoma.14 Other side effects of corticosteroid 
therapy include retardation of corneal epithelial healing, uveitis, mydriasis, ptosis and 
transient ocular discomfort.15 In the January 1993 issue of the Review of Optometry, the 
Optometric Study Center suggested some guidelines to follow for therapeutic 
management. These included a complete case history prior to initiating therapy, using the 
least number of drugs in the lowest concentrations and the least frequent doses for the 
condition, improving and monitoring patient compliance and carefully considering the 
risk of refilling prescriptions over the telephone.l6 Even though only a small percentage 
of your patients will be on heavy corticosteroid therapy, it is important to ensure that they 
are aware of the side effects as they may be irreversible. 
The included informed consent is not applicable to all patients on steroid therapy. 
For example, the chances of the side effects materializing is relatively low in the case of a 
post cataract patient who needs to be on steroid therapy for approximately one to two 
weeks. However, in the case of a chronic iritis patient who may need steroid therapy on 
and off for an unlimited period of time, it is appropriate to infom1 the patient and get 
his/her consent. Since the use of steroids is fairly limited, the use of such a consent form 
will also be limited and a short entry in the patient's record indicating that you have 
explained the possible side effects of steroid therapy may be adequate. 
INFORMED CONSENT AND PROLONGED STEROID THERAPY 
Ocular steroids may cause complications when used for a significant period of time. Some of these side 
effects are irreversible and others may need additional drug therapy in order to treat them. 
Cataract formation can occur as a side effect of prolonged steroid therapy. The probability of cataract 
formation increases with the strength of the drug and length of treatment. Studies have shown that adults 
who are on steroids for a period of 1-4 years are more likely to develop cataracts. 
Topical steroids can increase the pressure inside your eye. If this occurs the pressure usually returns to 
normall-3 weeks after steroid therapy is discontinued. This increase in pressure tends to run in families. 
Therefore, you may or may not respond to the steroid therapy. However, if the pressure in your eyes 
raises significantly inducing glaucoma, then additional medication may be needed to lower the pressure 
and prevent further complications. 
Other side effects may include an increased risk of infections, slower healing of your eyes, discomfort to 
your eyes, lid drooping and slight pupil enlargement. 
If you have any questions, please ask your doctor prior to signing the consent form. 
I understand that there may be certain complications associated with the steroid therapy that I am 
undergoing. 
Signature of the Patient/Parent/Guardian Date 
Signature of the Doctor Date 
Signature of a Witness Date 
Another area that lacks compliance and needs to be addressed is the therapeutic 
treatment of glaucoma. A practitioner may fail to fully inform the patient of the 
seriousness of the disease or the patient may simply choose not to comply because of 
inconvenience. The impact of both these issues can be lessened with an informed consent 
form. 
Studies have shown that the prevalence of primary open angle glaucoma in 
patients over the age of forty is 0.43 to 1.02%. 17 Even though this is a small percentage 
of patients, it is absolutely critical that they are educated on the occurrence, progression 
and treatment of glaucoma. Since there are several etiologies to the development of 
glaucoma, the eye care practitioner must sit down and spend some time explaining to the 
patient the most likely reason he/she has developed glaucoma. The basic mechanism of 
the progression of glaucoma is essentially the same in all patients. They must understand 
that the therapy they are undergoing is not a cure but instead significantly reduces the 
progression of the disease. They must also understand that poor compliance can lead to 
irreversible visual field loss and eventual blindness. 
Like every informed consent form, this one must inform the patient of the side 
effects of the medication(s) they are taking. Except for the carbonic anhydrase inhibitors 
and the cholinergic agonists, most of the anti-glaucoma medications have relatively mild 
side effects. Therefore, only the most potent side effects need to be identified. Since 
your staff members/technicians may write the side effects on the informed consent form, 
it may be a good idea to have a standardized list of the most potent side effects for each 
anti-glaucoma medication. Your staff can then simply copy them onto the form once you 
have selected the anti-glaucoma medication that is the best for the patient. 
Since each patient will be on a different medication or combination of 
medications the dosage must be entered on each form. For example, if you have decided 
to put your patient on Betoptic 0.5% BID then the informed consent form should be filled 
in the following manner: 
You have been put on the following medication: 
Betoptic 0.5% twice daily in each eye approximately 12 hours apart 
If the therapy regimen indicates that the drop needs to be administered more than once a 
day, the time period between drops must be specified to ensure patient compliance. 
INFORMED CONSENT AND GLAUCOMA THERAPY 
Glaucoma is a disease in which the pressure inside the eye is elevated. This may be due to the production 
of too much fluid inside your eye or the inability of a normal amount of fluid to drain from your eye. 
Your doctor can usually identify the cause of the glaucoma that you have. 
You have been put on the following medication(s): 
It is absolutely essential that you usc the medication as you have been directed. After instilling the 
drop(s) in your eye(s) close them for approximately 2 minutes and pinch the inside corners of your eyes. 
This allows the drop to stay in your eyes without draining into your nose and/or throat. This increases the 
effectiveness and decreases the side effects that the drops may have on your body. 
If you are using a new medication or one that you have not used before, please make sure you know what 
side effects can be expected. If you cannot tolerate the medication due to the side effects discontinue the 
medication and call our office to make an appointment as soon as possible. 
Since each medication causes several side effects only the most potent ones are identified below: 
--· 
I fully understand that the medication(s) that I am currently taking for the management of my glaucoma 
has the above side effects. I also understand that I need to instill the drops as I have been advised. If I do 
not comply with the dosage that my doctor has put me on then I am solely responsible for any vision loss 
that occurs due to my lack of compliance. 
Signature of the Patient/Guardian Date 
Signature of the Doctor Date 
CONCLUSION: 
Since a physician can be held liable for failure to obtain informed consent, he/she 
needs to provide the patient with all the information a reasonable patient will find 
necessary to make an intelligent decision about his/her medical care. 
The nature of a procedure, its risks and benefits, and the possible side effects must 
be disclosed and explained. If a particular diagnosis has been made, only the information 
pertinent to treatment needs to be disclosed not the diagnosis itself.? A patient must also 
be informed if they are at high risk for developing a disease. For both diagnostic and 
therapeutic procedures, alternative tests and/or treatment options should also be given to 
the patient. In most cases the alternative options are less preferred by the doctor as they 
may be less effective or may have an unusually high incidence of side effects. This must 
also be disclosed to the patient and informed consent should be obtained. 
As the health care system changes and as our patients become much more aware 
of the medical procedures and therapeutic treatment that they may undergo, we also need 
to be more concerned with the issue of informed consent. 
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